Fibrex Team
Prof. Thomas Thum
MD, PhD
Director of the Fraunhofer ITEM
Director of the IMTTS, MHH
CSO & Founder at Cardior
Leading cardiologist and a pioneer in RNA therapeutics for cardiovascular disease; has authored over 400 publications as a KOL in heart failure
Prof. Christian Bär
PhD
Research Group leader at IMTTS, MHH
Renowned scientist with expertise in cardiac regenerative strategies involving ncRNAs; expert for sophisticated preclinical rodent in vivo and human ex vivo models
Dr. Meike Drobe
Science Manager at IMTTS, MHH
8 years in managing and directing academic and industry-associated research projects along with public fundings
Dr. Anne Bührke
Postdoc at IMTTS, MHH
FIBREX Project Manager
Scientific expert in ncRNA therapeutics characterisation and development with a strong background in MEG3 biology
Expert Team
Dr. Ralf Cordes MBA | Technology Manager at Ascenion 15 years in supporting scientists in the preliminary phase of the patent application, in order to identify commercially attractive inventions at an early stage
|
Dr. Ulrich Granzer | Regulatory Affairs Consultant Granzer Regulatory Consulting & Services 25 years of experience in drug development and regulatory affairs; founder of Granzer Regulatory Consulting & Services
|
Dr. Arthur A. Levin PhD | CSO, Avidity Biosciences 20 years of knowhow in the research and development of RNA-targeting therapeutics; 30 years of experience in the pharmaceutical industry
|
Dr. Steffen Rump | Development Consultant SRConsulting More than 10 years experience in early drug development; specialist for CMC, non-clinical and clinical development of chemically synthesized oligonucleotide compounds |